Amcal Cranberry 10,000
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
29-09-2019
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Vaccinium macrocarpon, Quantity: 400 mg (Equivalent: Vaccinium macrocarpon, Qty 10 g)
Available from:
Sigma Company Limited
Pharmaceutical form:
Tablet, uncoated
Composition:
Excipient Ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; croscarmellose sodium; crospovidone; povidone; magnesium stearate; silicon dioxide
Administration route:
Oral
Therapeutic indications:
Helps reduce occurrence of medically diagnosed cystitis ; Helps decrease/reduce/relieve symptoms of medically diagnosed cystitis ; Maintain/support urinary tract health
Product summary:
Visual Identification: ;
Authorization status:
Listed
Authorization date:
2019-09-11
